Bicycle Therapeutics plc Contract with Customer, Asset, Sale
Bicycle Therapeutics plc (BCYC) reported Contract with Customer, Asset, Sale of $0 for the 12-month period ending 2020-12-31, per its 10-Q filed 2021-08-05.
Discontinued › Notes › Allowance for Credit Loss
us-gaap:ContractWithCustomerAssetSale · last filed 2021-08-05
- Bicycle Therapeutics plc contract with customer, asset, sale for the quarter ending 2019-12-31 was $46.00K.
- Bicycle Therapeutics plc contract with customer, asset, sale for the quarter ending 2019-09-30 was $103.00K.
- Bicycle Therapeutics plc contract with customer, asset, sale for fiscal 2019 was $149.00K, a 63.74% increase from fiscal 2018.
- Bicycle Therapeutics plc contract with customer, asset, sale for fiscal 2018 was $91.00K.
| Period end | Contract with Customer, Asset, Sale 3 month | Contract with Customer, Asset, Sale 6 month | Contract with Customer, Asset, Sale 9 month | Contract with Customer, Asset, Sale 12 month |
|---|---|---|---|---|
| 2020-12-31 | $0.00 10-Q · filed 2021-08-05 | |||
| 2019-12-31 | $46.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $149.00K derived: sum of 2 quarters · filed 2021-03-11 | $149.00K 10-K · filed 2021-03-11 | |
| 2019-09-30 | $103.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $103.00K 10-Q · filed 2019-11-07 | ||
| 2019-06-30 | $0.00 10-Q · filed 2019-08-08 | |||
| 2018-12-31 | $91.00K 10-K · filed 2020-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B |